Normalizing Complementary DNA by Quantitative Reverse Transcriptase–Polymerase Chain Reaction of β2-Microglobulin: Molecular Monitoring of Minimal Residual Disease in Acute Promyelocytic Leukemia
- 1 June 2000
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Diagnostic Molecular Pathology
- Vol. 9 (2), 98-109
- https://doi.org/10.1097/00019606-200006000-00006
Abstract
Reverse transcription (RT)-polymerase chain reaction (PCR) raises unique methodological matters that may hamper the reliability of the procedure, especially when results should direct therapeutic decisions. One of these matters is represented by the RT step. The present study shows that differences in complementary DNA (cDNA) preparations purposely containing increasing amounts of retrotranscribed RNA were not disclosed by nonquantitative RT-PCR by two different housekeeping genes, leading to fictitious results when the expression of a given gene was quantitatively assessed. To overcome this problem, the following are proposed: 1) to evaluate the efficiency of RT step through the quantification, by competitive RT-PCR, of the expression levels of the housekeeping gene beta2-microglobulin (beta2M); 2) to normalize each cDNA preparation to be comprised within 1 standard deviation of the mean value of beta2M absolute level (3.14 +/- 1.14 attomoles/microg RNA) found by analyzing 33 cell lines of hematopoietic origin. To validate this strategy in a clinical setting, serial cDNA samples from patients were checked by conventional and quantitative RT-PCR for beta2M. Again, only a quantitative evaluation of beta2M levels was allowed to unveil significant differences, otherwise undetected, in the efficiency of RT reactions among these cDNA samples. Normalization of samples to obtain cDNA preparations containing comparable beta2M levels, eventually led to an increased sensitivity in the detection of PML-RARalpha fusion transcripts. This approach seems of great value for the monitoring of minimal residual disease in serial patient samples when a tumor-specific marker is available.Keywords
This publication has 37 references indexed in Scilit:
- The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up‐regulated upon differentiationBritish Journal of Haematology, 1999
- Control genes in reverse transcriptase-polymerase chain reaction assaysLeukemia, 1997
- A commentary on the practical applications of competitive PCR.Genome Research, 1995
- Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.JCI Insight, 1995
- AnnotationBritish Journal of Haematology, 1995
- Detection of Chromosomal Translocations :in Leukemia-Lymphoma Cells by Polymerase Chain ReactionLeukemia & Lymphoma, 1995
- Human neutrophil granules and secretory vesiclesEuropean Journal of Haematology, 1993
- Competitive PCRNature, 1992
- Wound Macrophages Express TGF-α and Other Growth Factors in Vivo: Analysis by mRNA PhenotypingScience, 1988
- A human dihydrofolate reductase pseudogene and its relationship to the multiple forms of specific messenger RNAJournal of Molecular Biology, 1983